Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

Europe - FRA:B7E - DE000A0JM2M1 - Common Stock

19.6 EUR
-0.2 (-1.01%)
Last: 10/23/2025, 7:00:00 PM
Fundamental Rating

5

Overall B7E gets a fundamental rating of 5 out of 10. We evaluated B7E against 113 industry peers in the Capital Markets industry. While B7E belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. B7E has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

B7E had positive earnings in the past year.
B7E had a positive operating cash flow in the past year.
B7E had positive earnings in 4 of the past 5 years.
Each year in the past 5 years B7E had a positive operating cash flow.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

B7E's Return On Assets of 9.48% is amongst the best of the industry. B7E outperforms 88.50% of its industry peers.
The Return On Equity of B7E (20.25%) is better than 81.42% of its industry peers.
B7E's Return On Invested Capital of 6.33% is fine compared to the rest of the industry. B7E outperforms 73.45% of its industry peers.
The Average Return On Invested Capital over the past 3 years for B7E is below the industry average of 8.16%.
The last Return On Invested Capital (6.33%) for B7E is above the 3 year average (5.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROIC 6.33%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 11.71%, B7E is in line with its industry, outperforming 52.21% of the companies in the same industry.
In the last couple of years the Profit Margin of B7E has grown nicely.
With a Operating Margin value of 8.02%, B7E perfoms like the industry average, outperforming 53.98% of the companies in the same industry.
In the last couple of years the Operating Margin of B7E has grown nicely.
Looking at the Gross Margin, with a value of 49.70%, B7E is in the better half of the industry, outperforming 61.95% of the companies in the same industry.
B7E's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, B7E has about the same amount of shares outstanding.
B7E has more shares outstanding than it did 5 years ago.
The debt/assets ratio for B7E has been reduced compared to a year ago.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

B7E has an Altman-Z score of 2.23. This is not the best score and indicates that B7E is in the grey zone with still only limited risk for bankruptcy at the moment.
B7E's Altman-Z score of 2.23 is fine compared to the rest of the industry. B7E outperforms 68.14% of its industry peers.
B7E has a debt to FCF ratio of 4.61. This is a neutral value as B7E would need 4.61 years to pay back of all of its debts.
B7E has a Debt to FCF ratio of 4.61. This is in the better half of the industry: B7E outperforms 69.03% of its industry peers.
B7E has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
B7E has a better Debt to Equity ratio (0.32) than 61.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Altman-Z 2.23
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.73 indicates that B7E should not have too much problems paying its short term obligations.
B7E has a better Current ratio (1.73) than 77.88% of its industry peers.
A Quick Ratio of 1.39 indicates that B7E should not have too much problems paying its short term obligations.
The Quick ratio of B7E (1.39) is better than 76.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.39
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 292.72% over the past year.
Measured over the past years, B7E shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.00% on average per year.
The Revenue has decreased by -0.59% in the past year.
B7E shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.79% yearly.
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%

3.2 Future

The Earnings Per Share is expected to decrease by -28.54% on average over the next years. This is quite bad
B7E is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.37% yearly.
EPS Next Y-83.59%
EPS Next 2Y-54.07%
EPS Next 3Y-28.54%
EPS Next 5YN/A
Revenue Next Year-37.57%
Revenue Next 2Y-19.55%
Revenue Next 3Y-11.86%
Revenue Next 5Y-5.37%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.35, which indicates a rather cheap valuation of B7E.
B7E's Price/Earnings ratio is rather cheap when compared to the industry. B7E is cheaper than 98.23% of the companies in the same industry.
When comparing the Price/Earnings ratio of B7E to the average of the S&P500 Index (27.67), we can say B7E is valued rather cheaply.
A Price/Forward Earnings ratio of 20.54 indicates a rather expensive valuation of B7E.
B7E's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. B7E is cheaper than 65.49% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of B7E to the average of the S&P500 Index (23.33), we can say B7E is valued inline with the index average.
Industry RankSector Rank
PE 4.35
Fwd PE 20.54
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

95.58% of the companies in the same industry are more expensive than B7E, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, B7E is valued cheaper than 92.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.32
EV/EBITDA 3.26
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The decent profitability rating of B7E may justify a higher PE ratio.
A cheap valuation may be justified as B7E's earnings are expected to decrease with -28.54% in the coming years.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y-54.07%
EPS Next 3Y-28.54%

3

5. Dividend

5.1 Amount

B7E has a Yearly Dividend Yield of 3.27%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.63, B7E pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, B7E pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.27%

5.2 History

The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The Dividend Rate of B7E has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-54.07%
EPS Next 3Y-28.54%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

BLUE CAP AG

FRA:B7E (10/23/2025, 7:00:00 PM)

19.6

-0.2 (-1.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-20 2025-08-20
Earnings (Next)10-21 2025-10-21
Inst Owners26.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap88.00M
Revenue(TTM)174.60M
Net Income(TTM)20.44M
Analysts82.86
Price Target31.01 (58.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.27%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.73%
EPS NY rev (3m)-14.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-38.37%
Valuation
Industry RankSector Rank
PE 4.35
Fwd PE 20.54
P/S 0.5
P/FCF 6.32
P/OCF 4.34
P/B 0.87
P/tB 1.66
EV/EBITDA 3.26
EPS(TTM)4.51
EY23.01%
EPS(NY)0.95
Fwd EY4.87%
FCF(TTM)3.1
FCFY15.81%
OCF(TTM)4.51
OCFY23.03%
SpS38.89
BVpS22.48
TBVpS11.77
PEG (NY)N/A
PEG (5Y)0.13
Graham Number47.76
Profitability
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROCE 9.09%
ROIC 6.33%
ROICexc 9.23%
ROICexgc 16.8%
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
FCFM 7.97%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexgc growth 3Y54.39%
ROICexgc growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score8
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Debt/EBITDA 1.04
Cap/Depr 37.43%
Cap/Sales 3.64%
Interest Coverage 3.69
Cash Conversion 65.44%
Profit Quality 68.08%
Current Ratio 1.73
Quick Ratio 1.39
Altman-Z 2.23
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
EPS Next Y-83.59%
EPS Next 2Y-54.07%
EPS Next 3Y-28.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%
Revenue Next Year-37.57%
Revenue Next 2Y-19.55%
Revenue Next 3Y-11.86%
Revenue Next 5Y-5.37%
EBIT growth 1Y224.21%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-8.44%
EBIT Next 3Y-20.35%
EBIT Next 5Y-12.88%
FCF growth 1Y-38.99%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-27.35%
OCF growth 3Y1.47%
OCF growth 5Y47.8%